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Human T-cell lymphotropic virus type-1 (HTLV1) is a lymphotropic virus which can contribute to 
carcinogenesis in adult T-cell leukemia, myleopathy and other disorders. 20 million people are affected 
by this virus in the world. The aim of this study was to determine the incidence of human T-cell lymph 
tropic virus type 1 infection in patients referred to Emam’s hospital laboratory in Sari. A cross-sectional 
study was done in 2009 to 2010 based on the different patients that were referred to Emam`s hospital 
laboratory in Sari. Our samples were selected by simple random selection, after venous blood sample 
was centrifuged and reserved in -70°C. All the samples were tested by enzyme-linked immuno sorbent 
assay (ELISA). An ELISA positive result was checked by Western blot (WB) assays. Out of 1200 cases, 
776 were female (65%) with ages between 1 and 76 years old. Most of the cases were Mazandaranian 
(99%); although only one person was recorded as HTLV1 positive (0.08%). He was a 41 years old man, 
living in Sari, with high school education. He was married (one wife) without any risk factor in past 
medical history, such as surgery, transfusion and abuse of injection, but he had HBV infection. Most of 
the females were housewives and most of the males were non-governmental employees; moreover, 
diabetes was more common among them. The results of the samples show that 122 women were 
pregnant, 92 cases had transfusion and 642 cases had different surgery. It was observed that the 
incidence of HTLV1 infection was very rare in the north of Iran (Sari); therefore, the routine HTLV1 
screening was not recommended. 
 





Human T-cell lymphotropic virus type-1 (HTLV1) is a 
retrovirus which predominantly infects the T-cell 
(Hollsberg and Hafler, 1993) and has been recognized as 
the etiologic agent of a mature T-cell leukemia/ 
lymphoma (ATL) and a chronic myelopathy known as 
HTLV1 – associated myelopathy (HAM) / tropical spastic 
paraparesis (TSP). Also, it is the cause of uveitis, chronic 
arthropathy, Hashimoto thyroiditis and pulmonary 
alveolitis (Osame et al., 1986; Gessain et al., 1985). 




*Corresponding author. E-mail: javadneg@yahoo.com. 
sex, from mother to infant (in the course of breast feeding  
and transplacental), contaminated needles and blood 
transfusion (Monplaisir et al., 1993; Murphy et al., 1989). 
HTLV1 infection is endemic in certain geographical 
areas, including Japan, the Caribbean islands, Parts of 
Africa and Brazil (Yamaguchi, 1994; Cesarie et al., 1999; 
Shindo et al., 2002). In Iran, the first case of ATL was 
reported in 1986 and subsequently Mashhad has been 
recognized as an endemic area for HTLV1 infection 
(Farid et al., 1995). 
Patients with different etiology such as: malignancy, 
major thalassemia, hemodialysis, Gastro-intestinal (GI) 
disorders (hepatitis) and diabetes are at high risk of 
contacting HTLV1 infection due to their need for repeated  




Table 1. Age distribution and blood transfusion of HTLV1 study in different 











1-10 11 (1) 17 (1) 28 (2) 
11-20 33 (3) 27 (2) 60 (5) 
21-30 166 (14) 68 (6) 234 (60) 
31-40 156 (13) 68 (6) 224 (19) 
41-50 146 (12) 55 (4) 201 (16) 
51-60 147 (12) 57 (5) 204 (17) 
61 117 (10) 132 (11) 249 (21) 
Total 776 (65) 424 (35) 1200 (100) 




blood transfusion or needles (Taghavi and Fatemi, 2009). 
Therefore,    this    study   was   conducted  to  determine 
seroprevalence of HTLV1 infection in different patients 
from the central province of Mazandaran (Sari) in the 
north of Iran. 
 
 
MATERIALS AND METHODS  
 
A total of 1200 samples from different patients, such as different 
malignancies, diabetes mellitus, hepatitis and pregnancy were 
tested for HTLV1 specific antibodies from March 2009 to March 
2010. Serum samples were screened for HTLV1 specific anti body 
using ELISA (ELISA, Diapro, Italy). All of the ELISA positive 
samples were confirmed by western blotting analysis (WBI HTLV1 
blot 204 kit: gene lab diagnostic, Ltd).  
A questionnaire including questions about demographic status, 
type of disease, transfusion, needles and surgery was fitted by the 
medial student. The data were analyzed using descriptive test and 





Out of the 1200 patients that were tested for HTLV1 
specific antibody, the percentage of females was 65% 
(770) (Table 1). 
The history of transfusion was 92 cases (7/7%). Of 
these patients with transfusion, females were 39 cases 
while males were 53 cases. Small and large surgery was 
642 cases (53/5%) with one time surgery in 572 cases. In 
the female group, GI and urology surgery were more 
common and 122 persons were pregnant, while in the 
male group, urology, GI and orthopedic surgery were 
more common. More patients lived in Mazandaran 
province (1187, 99%), but more of the cases (934) 
become common, the more they move to Sari city (78%). 
The patients with other cases lived in other cities of 
Mazandaran province (Table 2), although few patients 
lived outside Mazandaran province (7, 1%). More 
patients (65%) had primary or high school education 
(under-diploma) (Table 3). Also, it was observed that 
more patients had only one partner, while 14 cases were 
found with two partners (1/2%).  
Basically, 340 cases were referred to the laboratory to 
fill the outpatient form (28/3%) (Table 4), but only one 
patient (41 years old) (0.08%) was found with hepatitis B 
infection, which supposedly resulted from HTLV1, without 
any history of surgery, transfusion or suspected needle. 






In this study, we showed the results of the presence of 
HTLV1 infection among different disorders in the north of 
Iran (Mazamdaran province). We evaluated different 
disorders including neurologic (such as multiple sclerosis, 
paralysis and tumor), gastrointestinal disorders (ulcer, 
inflammatory bowel diseases and tumors), hematology 
and oncology disorders (chronic anemia and malig-
nancies), urologic disorders (renal stone, malig-nancies 
and urinary tract infection), obstetric and gynecology 
disorders (pregnancy and malignancies) and other 
disorders, such as diabetics mellitus, thyroid diseases, 
pneumonitis, dermatitis and polymyositis. 
This study showed very low prevalence of HTLV1 
infection in different disorders (0.08%). This is compatible 
with some other geographic low endemic areas, where 
the seroprevalence of HTLV1 is generally low (Payne et 
al., 2004), but this infection is endemic in certain parts of 
Iran including Mashhad (Razavi province), in the East 
north of Iran (Farid et al., 1995; Mirsadraee et al., 2007). 
This result was lesser than that shown in major thalas-
semic patients in Sari where five cases of positive form 
288 (1/7%) was recorded (Unpublished by the author).  
The prevalence   of   HTLV1   infection   was  5/6  times 
higher in the  type 2  diabetic  population  than  the  blood 















Sari 639 (53) 298 (24/5) 934 (77/5) 
Neka 41 (3) 30 (2/5) 71 (5/5) 
Behshar 23 (2) 12 (1) 35 (3) 
Ghaemshar 33 (3) 36 (3) 69 (6) 
Savadkoh 1 (0/1) 6 (0/5) 7 (0/6) 
Joibar 16 (1/5) 10 (1) 26 (2/5) 
Amol 6 (0/5) 5 (0/5) 11 (1) 
Chaloos 2 (0/2) 1 (0/1) 3 (0/3) 
Nooshahr 1 (0/1) 3 (0/2) 4 (0/3) 
Mahmodabad 3 (0/2) 2 (0/2) 5 (0/4) 
Tonekabon 2 (0/2) 2 (0/2) 4 (0/3) 
Noor 1 (0/1) 3 (0/2) 4 (0/3) 
Kiasar 4 (0/3) 4 (0/3) 8 (0/6) 
Babolsae 3 (0/2) 3 (0/2) 6 (0/4) 
Lahijan 1 (0/1) ------------- 1 (0/1) 
Gorgan 2 (0/2) 3 (0/2) 5 (0/4) 
Semnan 1 (0/1) 2 (0/2) 3 (0/3) 
Tehran 2 (0/2) 2 (0/2) 4 (0/3) 
Total 776 (65) 424 (35) 1200 (100) 
 















Primary and high school  710 (59) 394 (32.5) 1004 (91.5) 
University  95 (5) 26 (2) 85 (7) 
Illiterate  9 (1) 4 (0/5) 15 (1/5) 




donor group (Hjelle et al., 1990). Also, this infection was 
higher  in    neurological     conditions     such   as  T  cell  
leukemia/lymphoma (ATLL), HAM/TSP, acute 
disseminated encephalomyeliti (ADEM), amyotrophic 
lateral sclerosis syndrome (ALS), myopathy, 
neuropathies and multiple sclerosis (MS) (Gastaldello et 
al., 2004; Iwasaki, 1990; Dalakas, 2006; Barkhaus and 
Morgan, 1988), but in our study, there were no positive 
cases in these groups. In other studies, HTLV1 infection 
and esophageal squamous cell carcinoma did not appear 
to have any significant correlation (Oger, 2007). In 
another study, concerning the prevalence of HTLV1, 
there was no statistical difference among the three 
groups including the representative population, 
neurological and non-neurological patients (1/2, 1/8 and 
1/6%), in the Lome teaching hospital (Togo) respectively. 
However, this was compatible with our study, but spastic 
paraparesis was the only disease that was significantly 
linked to HTLV1 (15/5%) (18). HTLV1 seroprevalence 
was 4/4% (75, 1727) in pregnancy cases (Carles, 2004), 
but all of the pregnant patients  were negative. Therefore, 
this region is not an endemic area for this virus and 
perhaps this is the best explanation for it from a lower 
seroprevalence of HTLV1 among the high risk patients in 
this region. 
Based on our results, the prevalence of the virus is 
lower than that in some other regions in Iran and other 
countries (Farid et al., 1995; Balogou et al., 2000). 
Conclusively, all evidence suggests that this virus is not 
endemic in this region of Iran (Sari, Mazandaran 
province); thus, there is no need for an HTLV1 screening 
test.  




Table 4. Distribution of different disorders in different patients with HTLV1 in Sari, 












Diabetes mellitus 205 (17) 78 (6/5) 283 23/5 
Orthopedic  42 (3/5) 45 (4) 87 (7/5) 
Hepatitis  10 (0/8) 18 (1/5) 28 (2/5) 
Hematologic 38 (3) 15 (1/25) 53 (4/5) 
ENT 2 (0/16) 4 (0/58) 9 (0/81) 
Malignancies  38 (3) 77 (5/8) 115 (9) 
Obstetric  143 (11/9) -------- 143 (12) 
Urologic 70 (5/8) 82 (6/8) 152 (12/5) 
Gastrointestinal 87 (7) 35 (2/9) 122 (10) 
Neurologic  45 (4) 38 (3) 83 (7) 
Endocrinology  35 (2/9) 13 (1) 48 (4) 
Dermatology  10 (0/8) 6 (0/5) 16 (1/5) 
Respiratory  30 (2/5) 6 (0/5) 36 (3) 
Cardiac  21 (1/75) 4 (0/3) 25 (2) 
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